دورية أكاديمية

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

التفاصيل البيبلوغرافية
العنوان: Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
المؤلفون: Legius, Eric, Messiaen, Ludwine, Wolkenstein, Pierre, Pancza, Patrice, Avery, Robert A, Berman, Yemima, Blakeley, Jaishri, Babovic-Vuksanovic, Dusica, Cunha, Karin Soares, Ferner, Rosalie, Fisher, Michael J, Friedman, Jan M, Gutmann, David H, Kehrer-Sawatzki, Hildegard, Korf, Bruce R, Mautner, Victor-Felix, Peltonen, Sirkku, Rauen, Katherine A, Riccardi, Vincent, Schorry, Elizabeth, Stemmer-Rachamimov, Anat, Stevenson, David A, Tadini, Gianluca, Ullrich, Nicole J, Viskochil, David, Wimmer, Katharina, Yohay, Kaleb, International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC), Huson, Susan M, Evans, D Gareth, Plotkin, Scott R
بيانات النشر: Elsevier BV
//dx.doi.org/10.1038/s41436-021-01170-5
Genet Med
سنة النشر: 2021
المجموعة: Apollo - University of Cambridge Repository
مصطلحات موضوعية: Cafe-au-Lait Spots, Consensus, Genetic Testing, Humans, Neurofibromatosis 1
الوصف: Funder: Children’s Tumor Foundation; doi: https://doi.org/10.13039/http://dx.doi.org/10.13039/100001545Test ; PURPOSE: By incorporating major developments in genetics, ophthalmology, dermatology, and neuroimaging, to revise the diagnostic criteria for neurofibromatosis type 1 (NF1) and to establish diagnostic criteria for Legius syndrome (LGSS). METHODS: We used a multistep process, beginning with a Delphi method involving global experts and subsequently involving non-NF experts, patients, and foundations/patient advocacy groups. RESULTS: We reached consensus on the minimal clinical and genetic criteria for diagnosing and differentiating NF1 and LGSS, which have phenotypic overlap in young patients with pigmentary findings. Criteria for the mosaic forms of these conditions are also recommended. CONCLUSION: The revised criteria for NF1 incorporate new clinical features and genetic testing, whereas the criteria for LGSS were created to differentiate the two conditions. It is likely that continued refinement of these new criteria will be necessary as investigators (1) study the diagnostic properties of the revised criteria, (2) reconsider criteria not included in this process, and (3) identify new clinical and other features of these conditions. For this reason, we propose an initiative to update periodically the diagnostic criteria for NF1 and LGSS.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf; text/xml
اللغة: English
العلاقة: https://www.repository.cam.ac.uk/handle/1810/326615Test
DOI: 10.17863/CAM.74064
الإتاحة: https://doi.org/10.17863/CAM.74064Test
https://www.repository.cam.ac.uk/handle/1810/326615Test
رقم الانضمام: edsbas.E96E0CA9
قاعدة البيانات: BASE